Eosinophilia and wheeze: thinking beyond asthma.

Stephanie L KuekColin PettmanMelanie R NeelandJoanne HarrisonSam MehrShivanthan ShanthikumarSean Beggs

Published in: Breathe (Sheffield, England) (2024)

Primary idiopathic hypereosinophilic syndrome is a rare condition that can cause end-organ damage in multiple systems. The advent of targeted monoclonal antibodies, such as mepolizumab, provides a safe and effective steroid-sparing treatment. https://bit.ly/4bgDP1u.

Keyphrases

chronic obstructive pulmonary disease
oxidative stress
lung function
case report
robot assisted
cystic fibrosis
drug delivery
combination therapy
replacement therapy